Enovis (ENOV) Non-Current Assets (2010 - 2026)
Enovis' (ENOV) quarterly Non-Current Assets came in at $2.6 billion in Q2 2026, down 29.1% year-on-year from $3.7 billion in Q2 2025, and down 1.34% on a QoQ basis from $2.6 billion in Q4 2025.
Enovis (ENOV) Non-Current Assets (2010 - 2026) Analysis & Trends
Enovis (ENOV) has 17 years of Non-Current Assets data on file, last reported at $2.6 billion in Q2 2026.
- On a quarterly basis, Non-Current Assets fell 29.1% year-over-year to $2.6 billion in Q2 2026; TTM through Apr 2026 was $12.1 billion, a 23.55% decrease from a year earlier, with the FY2025 full-year figure at $2.6 billion, down 26.44% from the prior year.
- Non-Current Assets for Q2 2026 stood at $2.6 billion, down from $2.6 billion in the prior quarter.
- Over the last five years, Non-Current Assets for ENOV reached as high as $4.3 billion in Q3 2024 and fell as low as -$547.7 million in Q2 2022.
- Historically, Non-Current Assets has averaged $3.3 billion across 5 years, with a median of $3.5 billion in 2023.
- Across the five-year window, Non-Current Assets tumbled 109.15% in 2022 and surged 732.87% in 2023, its largest moves.
- Year by year, Non-Current Assets stood at $3.5 billion in 2022, then advanced by 3.87% to $3.6 billion in 2023, then fell by 1.12% to $3.6 billion in 2024, then retreated by 26.44% to $2.6 billion in 2025, then decreased by 1.34% to $2.6 billion in 2026.
- Per Business Quant data, the three most recent Non-Current Assets figures were $2.6 billion in Q2 2026, $2.6 billion in Q4 2025, and $3.2 billion in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.30 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 20.47 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 26.70 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 6.35 Bn |
| 10 | Enovis | 1.50 Bn | 1.47 Bn | 365.49 Mn | 2.59 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 2.59 Bn |
| Dec 31, 2025 | 2.63 Bn |
| Oct 3, 2025 | 3.15 Bn |
| Jul 4, 2025 | 3.74 Bn |
| Apr 4, 2025 | 3.66 Bn |
| Dec 31, 2024 | 3.57 Bn |
| Sep 27, 2024 | 4.35 Bn |
| Jun 28, 2024 | 4.27 Bn |
| Mar 29, 2024 | 4.33 Bn |
| Dec 31, 2023 | 3.61 Bn |
| Sep 29, 2023 | 3.55 Bn |
| Jun 30, 2023 | 3.56 Bn |
| Mar 31, 2023 | 3.47 Bn |
| Dec 31, 2022 | 3.48 Bn |
| Sep 30, 2022 | 3.44 Bn |
| Jul 1, 2022 | 3.43 Bn |
| Apr 1, 2022 | -547.74 Mn |
| Dec 31, 2021 | 6.21 Bn |
| Oct 1, 2021 | 6.25 Bn |
| Jul 2, 2021 | 6.08 Bn |